Sierra Oncology Inc (SRRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 67,694 | 78,831 | 90,908 | 106,046 | 116,128 |
| TOTAL | $70,812 | $82,592 | $94,607 | $108,752 | $119,331 |
| Non-Current Assets | |||||
| PPE Net | 137 | 134 | 150 | 168 | 125 |
| Other Non-Current Assets | 1,368 | 1,449 | 1,338 | 549 | 596 |
| TOTAL | $1,505 | $1,583 | $1,488 | $717 | $721 |
| Total Assets | $72,317 | $84,175 | $96,095 | $109,469 | $120,052 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,171 | 668 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,304 | 1,203 | 619 | 1,287 | 962 |
| Accrued Expenses | 6,738 | 7,064 | 6,619 | 8,812 | 7,168 |
| TOTAL | $9,213 | $8,935 | $7,238 | $10,099 | $8,130 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,841 | 4,303 | 4,763 | 4,891 | 4,856 |
| Other Non-Current Liabilities | 415 | 466 | 503 | 0 | 0 |
| TOTAL | $4,256 | $4,769 | $5,266 | $4,891 | $4,856 |
| Total Liabilities | $13,469 | $13,704 | $12,504 | $14,990 | $12,986 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,867 | 1,867 | 1,867 | N/A | N/A |
| Common Shares | 74 | 74 | 74 | 74 | 74 |
| Retained earnings | -718,225 | -705,322 | -690,444 | -677,412 | -663,129 |
| TOTAL | $58,848 | $70,471 | $83,591 | $94,479 | $107,066 |
| Total Liabilities And Equity | $72,317 | $84,175 | $96,095 | $109,469 | $120,052 |